Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

4.95
Delayed Data
As of Jan 12
 -0.05 / -1.00%
Today’s Change
1.50
Today|||52-Week Range
5.75
+30.26%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close5.00
Today’s open4.95
Day’s range4.80 - 5.35
Volume1,188,617
Average volume (3 months)1,423,469
Market cap$392.6M
Data as of 4:00pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)+2.42%
Earnings growth (this year)--
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+77.60%
P/E ratioNM
Price/Sales30.27
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.00-0.00%
CDMOAvid Bioservices Inc+0.02+0.53%
MRTXMirati Therapeutics ...+1.55+6.68%
VCELVericel Corp+0.17+2.71%
Data as of 4:00pm ET, 01/12/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$8.2M
Annual profit (last year)-$60.9M
Net profit margin-747.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Henry H. Ji
Chief Financial Officer
John Liatos
Corporate headquarters
San Diego, California

Forecasts